Delivery Order SPE2DB20D3303-SPE2DB25FA3JB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Losartan Potassium 50 mg tablets (1,000 count) with a ceiling value of $1,061.64. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the contractor. The order is scheduled for ultimate completion by September 15, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units. The contract carries a ceiling value of $19,708.52 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 15, 2025. This award was made on a competitive basis without set-aside designation, with performance to be executed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,151.65. This is a firm fixed price delivery order with an ultimate completion date of August 21, 2025. The award was not set-aside and represents a competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units, with a ceiling value of $1,663.10. This firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was awarded competitively without set-aside provisions, reflecting AmerisourceBergen's capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Losartan Potassium 25 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,674.46. This award is issued as a firm fixed price delivery order with an ultimate completion date of June 25, 2025, and represents a non-competitive set-aside award. The contract is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.76 on July 28, 2025, for the supply of Losartan Potassium 25 mg tablets in quantities of 1,000 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 29, 2025, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction typical of routine pharmaceutical procurement operations supporting...
- The Defense Logistics Agency awarded a Delivery Order contract to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units, with a ceiling value of $1,221.28 and an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of 1,000 tablets of Losartan Potassium 100 mg, valued at $3,470.22. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Losartan potassium is a generic antihypertensive...
- The Defense Logistics Agency awarded a delivery order valued at $1,011.75 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of 1,000 tablets of Losartan Potassium 50 mg. This contract represents a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,414.81 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. This award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3JBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Losartan Potassium 50 mg tablets (1,000 count) with a ceiling value of $2,134.71. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by September 8, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical commodities to support military and veteran healthcare systems. The parent contract serves as a global pharmaceutical support vehicle enabling the company to provide brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/5/25 |